Delivery Order SPE2DB22D9239-SPE2DB25FDL01
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,073.80 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, on September 24, 2025. This firm fixed-price delivery order is for 240 units of Alecensa 150 mg capsules, an oncology medication used in cancer treatment. The contract contains no set-aside designation and is scheduled for ultimate completion by October 16, 2025, with performance taking place at...
- The U.S. Defense Logistics Agency (DLA), acting through the Medical Supply Chain organization, awarded a delivery order to DMS Pharmaceutical Group Inc. on June 9, 2025, for the supply of Alecensa 150 mg capsules in quantities of 240 units. This firm fixed-price delivery order, valued at $38,346.96, represents a single task issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with DLA under the SPE2DB program, which carries a maximum value of $499,999,999 and extends...
- The Defense Logistics Agency awarded a $25.6K firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 240 units of Alecensa 150 mg capsules. The contract was awarded on September 18, 2025, with an ultimate completion date of October 9, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued...
- On May 14, 2025, the Defense Logistics Agency awarded a firm fixed-price delivery order valued at $12,782.32 to DMS Pharmaceutical Group Inc. for the supply of Alecensa (150 mg capsules, 240 count). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform delivery from its Park Ridge facility, with an ultimate completion date of June 5, 2025. This delivery order was not issued under any set-aside designation and...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa (alectinib) 150 mg capsules in quantities of 240 units. This $12,782.32 firm fixed-price delivery order was awarded on September 15, 2025, with an ultimate completion date of October 6, 2025. The contract carries no set-aside designation, and performance will occur at the contractor's Park Ridge...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,782.32 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-count units). This firm fixed-price delivery order, issued on April 24, 2025, with an ultimate completion date of May 15, 2025, represents a continuation of the companies' established relationship under the larger pharmaceutical supply framework....
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-count units). This firm fixed-price delivery order, awarded on July 21, 2025, carries a ceiling value of $12,782.32 and is scheduled for ultimate completion by August 11, 2025. The contract was awarded without a set-aside designation, allowing DMS Pharmaceutical Group to compete...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order by the Defense Logistics Agency (DLA) on July 14, 2025, for the supply of Alecensa 150 mg capsules (240-count units) with a ceiling value of $25.6K. This delivery order, which carries no set-aside designation, is scheduled for completion by August 4, 2025, and will be performed at the contractor's facility in Park Ridge, Illinois....
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-unit quantity) with a ceiling value of $25,564.66. This firm fixed-price delivery order, awarded on August 18, 2025, with an ultimate completion date of September 9, 2025, carries no set-aside designation. The award falls under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,782.32 to DMS Pharmaceutical Group Inc. for the supply of Alecensa 150 mg capsules (240 count units). The contract was awarded on August 29, 2025, with an ultimate completion date of September 22, 2025, and carries a firm fixed-price structure with no set-aside designation. The delivery location is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its headquarters operations. DMS Pharmaceutical Group Inc., a...
- SPE2DB22D9239Indefinite Delivery Contract
- SPE2DB22D9239-SPE2DB25FDL01Delivery Order
On August 8, 2025, the Defense Logistics Agency (DLA) awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alecensa 150 mg capsules (240-count units). This firm fixed-price delivery order, valued at $38,346.96, represents fulfillment under the agency's larger SPE2DB Indefinite Delivery Contract with DMS Pharmaceutical Group, a $499.9 billion vehicle valid through November 2026. The delivery order carries no set-aside designation, and the ultimate completion date is scheduled for August 29, 2025, with performance to occur at the contractor's Park Ridge, Illinois facility. Alecensa is an oncology medication used in the treatment of advanced non-small cell lung cancer, reflecting the DLA's ongoing requirement to supply specialized pharmaceutical products to military health facilities and Department of Defense healthcare sites worldwide. DMS Pharmaceutical Group has established itself as a critical supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively while maintaining a robust portfolio of contract awards for branded and generic prescription drugs, biologics, and medical consumables across multiple therapeutic categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $38.3k | 8/8/25 |